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Rasmussen H (1960) Acta oto-laryng. (Stockh.) 52, 519 DISCUSSION Mr J C Jenkins (Leicester) said that when applying any physical force therapeutically to the body it was essential to measure that force. Thus when ultrasound was switched on, pressure ofthe emerging energy must be known. Therefore before applying this force, the output of the producing apparatus must be checked and calibratedsince all machines, particularly electrical, were liable to temperament.
Ultrasonic waves were vibratious occurring in matter at frequencies measured in millions of cycles per second (MHz) -usuaJly, in medicine, 1-3 MHz. They were produced by an electrical generator which would supply an oscillating current of approximately 3 MHz and this was fed to a quartz crystal or ceramic which transformed the electrical energy to ultrasonic sound waves at 3 MHz. To check the output of ultrasound from the tip of the applicator, an intensity meter was necessary and this took the form of a simple balance. Ultrasonic energy travelling through water exerted a one-way push away from its source and this pressure could be balanced against a weight at the rate of 66 67 mg per watt of acoustic power. In Leicester two types of generator with their intensity meters were used, and there was a Physics Department which now also kindly carried out this important work.
To deliver the ultrasound precisely to the pituitary gland the most accurate way, at least for early cases, was via the double approach, as practised by Mr Geoffrey Bateman and others. By this means the tip of the probe could be applied, under direct vision, closely on to the dura covering the pituitaryand direct contact was necessary since ultrasound did not pass through air except with difficulty.
The ensuing film demonstrated the technique of calibration for the two types of generator used at Leicester. Micheli & Parisio 1963 , Maurici 1963 , Milton & Brown 1965 and Pantazopoulos 1965 . Few of these series comprise more than two or three personal cases, thus limiting their value when comparing different forms of treatment or evaluating the natural history of this disease. This paper is based on personal experience of 10 patients with malignant melanoma in the nose seen in the Royal National Throat Nose and Ear Hospital and an additional 15 patients treated at this Hospital by colleagues, whose notes have been made available for study.
It has been estimated that the incidence of malignant melanoma in the whole body is approximately 2 new cases per 100,000 population per year (Petersen et al. 1962) . When two large series of cases with this disease are combined (Moore & Martin 1955 , Pack et al. 1952 , in only 46 instances of 1,190 patients was the lesion found in the mouth or nose (1V7%). Allen & Spitz (1953) , investigating 934 cases of malignant melanoma, found only 0-85 % occurring in the nose, while Moore & Martin (1955) , investigating 1,546 cases, gave a figure of 0-5 %. With these figures in mind it is obvious that a series of 25 cases represents an unusually wide experience of an exceptionally uncommon condition.
Malignant melanomata in the nasal cavity are usually primary since there is rarely a history of previous skin lesions. Ringertz (1938) noted only two cases of proven secondary melanoma in the nasal cavityone additional case is reported in this paper. However, Attie & Khafif (1964) in their excellent monograph on melanotic tumours say that the majority of mucosal lesions are metastatic since no junctional changes are found and a study of the normal mucosa invariably fails to reveal the presence of melanocytes.
In the embryo, neural crest cells migrate to the dermis of the skin, to the substantia propria of mucous membrane and to the basal cells of skin and mucous membrane. They are all precursors of melanocytes. Although the former usually disappear after birth, the melanocytes at the basal layer of the skin and mucous membranes persist throughout life as dendritic secretory cells which can transmit melanin granules to the surrounding epithelial cells (Reese & Morgan 1967) . Localized proliferation of these sites can produce a junctional, dermal or compound navus, lesions not uncommonly found on the conjunctiva, but which may also occur in mucous membranes less easily visible such as in the nasal passages.
The majority of malignant melanomata originate in either the anterior part of the nasal septum or the middle and inferior turbinals. Yet benign melanomata are extremely rare at these sites and obvious pigment is lacking in the nasal mucosa except in the olfactory area. Despite the absence of definite histological evidence the majority of malignant nasal melanomata must be primary tumours for they cannot all be metastatic lesions from undetected malignant skin melanoma: secondary deposits in the nose are an extremely rare occurrence in known skin melanomata, only a few cases being reported in the literature.
Historical Aspects
Eiselt in 1862, when discussing pigmented tumours, says that Highmore (1651) talked of 'fatal black tumours with metastases and black fluid in the body'. The term melanoma was first used by Carswell in 1838. It is interesting to recall that in contradistinction to our anxious speculation when viewing a patient's mole today, the possession of these pigmented areas was deemed highly desirable in the eighteenth century. If a lady was not blessed with these blemishes by nature, then she was forced to fabricate them from black plaster, attaching them to various areas of her body. The most interesting testimony to the antiquity of this tumour is exhibited in Peruvian mummies estimated to be 2,400 years old. Examination revealed rounded melanotic masses in the skin and diffuse metastases to the bones of the skull and extremities (Urteaga & Pack 1966 ).
Clinical Features
Allen & Spitz (1953) quote a figure of 62-7 % of all cases of malignant melanoma as occurring in the fourth to sixth decades of life. This is similar to the incidence given by Conley (1966) for this disease affecting the head and neck. In my small series the incidence within this age group is 68 % with a slightly increased number of males to females. Most reports indicate that males and females are subject to this disease to the same degree and there is certainly insufficient evidence to suggest that this is not so when the disease occurs primarily in the nasal cavity.
The patient's symptoms are of little help in diagnosis although the frequency of epistaxis should suggest the possibility of malignancy. Inspection of the nasal cavity may reveal a sessile tumour, polyp or large obstructing mass. Experience with this particular group of patients and from those reported in the literature confirms that most of these neoplasms originate on the septum or middle/inferior turbinals. Occasionally the tumour can be seen at the vestibular mucocutaneous junction ( Table 1 ). The melanoma is frequently pigmented but the presence of pigment may change throughout the course of the disease. This variation in pigmentation of primary, local recurrence or metastases, does not appear to influence the long-term prognosis of the patient.
Diagnosis of this condition can only be established by biopsy, particularly as the amelanotic tumour may clinically resemble a carcinoma, a far commoner condition in the nose. Even histological difficulty may be experienced and the use of histochemical, biochemical and histophotometric techniques may all be necessary to establish diagnosis. Histologically the cells of malignant melanomata are similar to those of benign pigmented naevi, in origin and to a degree in appearance and mode of differentiation, but they show more pronounced atypia. Some authorities stress the importance of junctional activity although this may be difficult to demonstrate in ulcerating lesions. Even the presence of pigment does not automatically diagnose malignant melanoma, since hemosiderin can cause deep pigmentation (Ravid & Estaves 1960) . It would appear that there is considerable need for pathological research on this interesting tumour, especially where the primary occurs on apparently nonpigmented mucosa.
,Etiology A variety of factors have been incriminated in the transformation of benign skin naevi into malignant melanomata. Physical trauma, exposure to sunlight (Davis et al. 1966) , and chronic infection have all been blamed with minimal evidence. Recent work in Uganda by M G Lewis (1967, personal communication) certainly suggests that 
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Died 38 months malignant melanoma on the sole of the foot in that country is strongly related to the frequent presence of pigmented spots at this site. It is the custom in Uganda to treat all lesions on the foot by applying a hot nail and it is suggested that the effects of this trauma may have a deleterious effect on an unstable pigmented area.
The anterior part of the nose is an accessible and frequent site of trauma from the finger nail but an analysis of this series shows that 60% of the lesions occurred in the left nose whereas traumatic 'nose picking' epistaxis is more usually found on the right. If trauma were an important cause of malignant melanoma then the incidence in the buccal mucosa, where chronic irritation and pigmentation is frequent, should be much greater than is the case.
Significance ofLymph Node Involvement
The most generally accepted treatment for malignant melanoma of the skin is wide excision of the primary lesion followed by block dissection of the regional lymph nodes. Mundth et al. (1965) found that the five-year survival rate for patients having prophylactic removal of regional nodes was 77 % when the nodes were uninvolved but dropped to 22 % when dissection was delayed until clinically positive nodes were detected. Conley (1967, personal communication) emphasizes that this approach is not necessarily applicable to melanoma of the nasal cavity since in-continuity resection of the primary lesion and its regional lymphatic field is not possible. In addition the lesion may be multicentric in origin; this together with the relatively late diagnosis is consistent with the extremely poor prognosis.
Only 2 of the 25 in this series presented with a palpable lymph node, in both patients in the submandibular region. One was treated by local excision of primary and metastases, dying 4 years later from melanomatosis. The other died within 4 months, untreated.
Of the remaining 23 patients, 8 developed metastatic deposits in the cervical lymph nodes at some time during their disease. The longest interval between diagnosis of the primary lesion and lymph node involvement was 4 years; this patient died 6 months after radical block dissection. Another patient had 6 separate metastatic nodes removed over a period of 5 years, the local lesion having been controlled. He died eventually with melanomatosis.
Experience with this group of patients suggests that primary presentation with lymph node in-volvement is uncommon. However when local metastases occur, then excision of the involved node is effective and, providing the local lesion is controlled, this treatment may offer lengthy palliation or even cure.
Treatment (Table 2) Wide surgical excision with in-continuity removal of regional lymph nodes is manifestly impracticabfe when dealing with lesions in the nasal passages since those tissues lying between primary site and regional nodes must inevitably remain untouched and untreated. Experience has shown that primary presentation with lymph node metastasis is uncommon. In those patients who develop metastasis later local excision of individual lymph nodes can be unexpectedly successful although radical block dissection is theoretically preferable.
Whatever the arguments for and against 'prophylactic' block dissection there can be no doubt that the primary lesion must be excised as widely as is technically feasible. In disease of the nasal passages this entails either a lateral rhinotomy or Rouge's appioach to the nasal septum. Most cases presenting with advanced disease will require removal of the whole mucosal covering of floor and lateral wall of nose. Since the involved mucosa is easily removed from underlying bone the latter can be left although it has been my practice, in all except purely septal melanoma, to remove the bony medial wall of the maxillary antrum. All three turbinals are sacrificed in such cases since the risk of local recurrence, either from inadequate resection or from multifocal disease, is high. Of the 6 patients dying within one year of diagnosis, 4 had been treated with inadequate surgical resections, such as a Caldwell Luc (Table  3) . Complete resection of the nose may be necessary; replacement by a well designed prosthesis renders this procedure less mutilating than may be thought. However it is doubtful if resection of the cribriform plate area is ever of value and such cases may be best treated by intraarterial chemotherapy (Case 25).
Radiotherapy is only of limited value in the treatment of malignant melanoma, a lesion that is generally regarded as radioresistant. However Mundth et al. (1965) found that one-third of his patients had a beneficial response to radiotherapy and in this group of patients those receiving a combination of surgery and radiotherapy showed a greatly improved prognosis over other forms of treatment.
The experiences of Creech et al. (1959) and Golomb et al. (1962) with regional perfusion of Table J   Results of treatment   Dead wvithin Survived   Treatment  No. ofcases I year  1 year 3 years 5 years  Surgery  8  4  2  2  0  Surgery with 16  2  8  3  3 radiotherapy Radiotherapy 1 0 0 0 1 cytotoxic drugs in cases of recurrent melanoma confined to the limbs have been encouraging. The problems encountered in 'vascular isolation' of the nasal passages are considerable. Despite this it is possible to inject many alkylating agents into the arterial supply of the nose whilst protecting the patient from toxic side-effects by means of whole body hypothermia (Harrison 1967) . This was carried out with Case 25 where three separate doses of a bis-epoxide Epodyl (ICI) were injected into the internal carotid arteries. Complete resolution of the local disease (recurrent melanoma on the cribriform plate following excision of the nose) was obtained. The patient eventually died with a solitary metastasis in a thoracic vertebra producing paraplegia but without recurrence of local disease.
The role of chemotherapy in this disease has yet to be established and the use of systemic chemotherapy with drugs such as phenylalanine mustard has proved in my hands to be both ineffective and highly toxic. However radical surgery combined with intra-arterial injection of shortlived alkylating agents under hypothermia may well prove to be the treatment of choice in melanoma of the nasal passages.
Factors influencing Prognosis
The prognosis in all mucosal melanomas is grave. The significance of metastatic deposits in the regional lymph nodes has already been discussed. All except one of the patients presenting with or developing metastatic deposits in a lymph node died of melanoma. In two of these patients the survival time was more than four years after removal of the first lymph node.
Patients with malignant melanoma may excrete urine containing abnormal metabolic products which darken on exposure to air. Crawhall et a!. (1966) investigated this occurrence in 32 patients and found that ofthe 7 patients with melanogenuria all died within 14 months. Few of the patients in this series had other than occasional urine tests for melanin. Case 24 had hepatomegaly and melanogenuria 3 years before his death from melanomatosis. Intensive chemotherapy with cyclophosphamide was given and the liver decreased in size, with disappearance of melanogenuria. The significance of this finding remains obscure since post-mortem revealed no evidence of the hepatic scarring which might have been expected if a metastasis had been previously destroyed. This particular patient had metastatic disease present in the neck for 5 years, the involved lymph nodes being removed whenever their size became an s embarrassment. The primary lesion was removed surgically and never recurred. In those patients surviving long periods of time with recurrent or metastatic disease, there appears to be a symbiotic relationship between host and tumour. As yet there is no evidence to relate this to the host/ tumour response but it is important to bear this possibility in mind, since this delicate balance may well be disturbed by over-enthusiastic therapythis applies particularly to the use of immune suppressant chemotherapeutic drugs.
Experience gained in assessing and caring for the patients reported in this series confirms previous reports that malignant melanoma affecting the nasal passages is an extremely lethal disease. But provided the primary lesion is treated adequately the expectation of life can be measured in years rather than months. In recent years a considerable amount of knowledge has been accumulated concerning the mechanism of melanin formation and the pathogenesis of melanotic tumours. It is to be hoped that further research may lead to the control of this disease, not by surgery or radiotherapy, but by a direct biochemical attack upon the melanocyte itself.
